MYCN and neuroblastoma: Taken together, our in vitro data demonstrate that PRMT5 supports the fitness, survival, and proliferation of MNA neuroblastoma via diverse mechanisms including previously reported pathways such as mRNA splicing and DNA repair, but also novel routes such as MYCN-mediated transcriptional regulation, glutamine metabolism and epitranscriptome regulation.